戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 biogenesis andbeta-oxidation byatRA requires peroxisome proliferator activated receptor delta.
2 nstream genes including c-Myc, cyclinD1, and peroxisome proliferator-activated receptor delta.
3 r via the activation of the nuclear receptor peroxisome proliferator-activated receptor delta.
4 me proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-delta.
5 in (a PKCbeta inhibitor) or with GW501516 (a peroxisome proliferator-activated receptor delta activat
6 e in the differentiation of sebocytes, while peroxisome proliferator-activated receptor delta activat
7        Conversely, exogenous prostacyclin or peroxisome proliferator-activated receptor-delta agonist
8  growth hormone secretagogue ibutamoren, the peroxisome proliferator-activated receptor-delta agonist
9    Linoleic acid and carbaprostacyclin, both peroxisome proliferator-activated receptor delta and alp
10 ing associated with efferocytosis, including peroxisome proliferator-activated receptor delta and CX3
11       NO donors stimulated the expression of peroxisome proliferator-activated receptor-delta and c-m
12 with a prostacyclin receptor antagonist or a peroxisome proliferator-activated receptor-delta antagon
13                Pharmacological activation of peroxisome proliferator-activated receptor delta/beta (P
14  gamma and alpha activation, suggesting that peroxisome proliferator-activated receptor delta is invo
15                                   PPARdelta (peroxisome proliferator-activated receptor delta) is a r
16 ecay accelerating factor, and transactivates peroxisome proliferator-activated receptor delta, leadin
17                         Acyl-CoA oxidase and peroxisome proliferator-activated receptor delta mRNA le
18                                 In contrast, peroxisome proliferator-activated receptor delta mRNA wa
19                                Generation of peroxisome proliferator-activated receptor delta null ma
20 lation of SIRT1 and hence TF by prostacyclin/peroxisome proliferator-activated receptor-delta pathway
21      These targets include cyclooxygenase-2, peroxisome proliferator activated receptor- delta, perox
22 viously unknown promyelocytic leukemia (PML)-peroxisome proliferator-activated receptor delta (PPAR-d
23                                We found that peroxisome proliferator-activated receptor delta (PPAR-d
24      Mechanistically, a HFD induces a robust peroxisome proliferator-activated receptor delta (PPAR-d
25 elpar is a potent, selective agonist for the peroxisome proliferator-activated receptor-delta (PPAR-d
26                            Here we show that peroxisome proliferator-activated receptor-delta (PPAR-d
27                                              Peroxisome proliferator-activated receptor-delta (PPAR-d
28                                              Peroxisome proliferator-activated receptor-delta (PPAR-d
29 posis, with a selective synthetic agonist of peroxisome proliferator-activated receptor-delta (PPAR-d
30                                              Peroxisome proliferator-activated receptor delta (PPARde
31 uscle, together with increased expression of peroxisome proliferator-activated receptor delta (PPARde
32 etic evidence demonstrating that deletion of peroxisome proliferator-activated receptor delta (PPARde
33                                              Peroxisome proliferator-activated receptor delta (PPARde
34                                              Peroxisome proliferator-activated receptor delta (PPARde
35                                              Peroxisome proliferator-activated receptor delta (PPARde
36         Recently, emerging data suggest that peroxisome proliferator-activated receptor delta (PPARde
37 inated elevation of mRNA levels of ACSL3 and peroxisome proliferator-activated receptor delta (PPARde
38                                  The nuclear peroxisome proliferator-activated receptor delta (PPARde
39 screening hit to highly potent and selective peroxisome proliferator-activated receptor delta (PPARde
40   Activation of the nuclear hormone receptor peroxisome proliferator-activated receptor delta (PPARde
41       To address this question, we evaluated peroxisome proliferator-activated receptor delta (PPARde
42                                              Peroxisome proliferator-activated receptor delta (PPARde
43 -3epsilon promoter activation is mediated by peroxisome proliferator-activated receptor delta (PPARde
44                                              Peroxisome proliferator-activated receptor delta (PPARde
45                 Based on recent reports that peroxisome proliferator-activated receptor delta (PPARde
46                The most potent and selective peroxisome proliferator-activated receptor delta (PPARde
47 geting of the nuclear prostaglandin receptor peroxisome proliferator-activated receptor delta (PPARde
48 clin responsive nuclear transcription factor peroxisome proliferator-activated receptor delta (PPARde
49 igand activation of the transcription factor peroxisome proliferator-activated receptor delta (PPARde
50                                          The peroxisome proliferator-activated receptor-delta (PPARde
51                                           As peroxisome proliferator-activated receptor-delta (PPARde
52                                              Peroxisome proliferator-activated receptor-delta (PPARde
53 ated by elevated plasma free fatty acids via peroxisome proliferator-activated receptor-delta, presum
54 (including epidermal growth factor receptor, peroxisome proliferator-activated receptor delta, prosta
55 Moreover, FAs from higher lipolysis activate peroxisome proliferator-activated receptor delta to indu

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。